Saturday, June 10, 2023 9:02:06 PM
OJ,
I agree with you and in fact I asked the question shortly after his presentation if the T-cell related materials he spoke of had been presented previously at one of the appearance by Dr. Liau or others that I hadn't seen. No one answered.
I don't doubt that anything he said wasn't true, but at some point it should be used in a peer reviewed presentation. Frankly it's unusual for a company to provide detailed scientific information that hasn't been peer reviewed. Perhaps when Dr. Liau appears in behalf of the company it will be presented and constitute peer review, though I'm uncertain that's the case.
Frankly it's hard to believe that this wasn't included in the Journal if it was known at the time, I can only guess that it really hadn't been discovered until more recently. Remember it's contractors who put everything from the trial together, it's very possible that they didn't delve into T-cells until many other things were completed, and perhaps they found much more than they ever anticipated.
Gary
I agree with you and in fact I asked the question shortly after his presentation if the T-cell related materials he spoke of had been presented previously at one of the appearance by Dr. Liau or others that I hadn't seen. No one answered.
I don't doubt that anything he said wasn't true, but at some point it should be used in a peer reviewed presentation. Frankly it's unusual for a company to provide detailed scientific information that hasn't been peer reviewed. Perhaps when Dr. Liau appears in behalf of the company it will be presented and constitute peer review, though I'm uncertain that's the case.
Frankly it's hard to believe that this wasn't included in the Journal if it was known at the time, I can only guess that it really hadn't been discovered until more recently. Remember it's contractors who put everything from the trial together, it's very possible that they didn't delve into T-cells until many other things were completed, and perhaps they found much more than they ever anticipated.
Gary
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
